Oren Gilad
2023
In 2023, Oren Gilad earned a total compensation of $877.4K as President and Chief Executive Officer at Aprea Therapeutics, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $246,950 |
|---|---|
| Option Awards | $60,160 |
| Salary | $550,000 |
| Stock Awards | $20,320 |
| Total | $877,430 |
Gilad received $550K in salary, accounting for 63% of the total pay in 2023.
Gilad also received $247K in non-equity incentive plan, $60.2K in option awards and $20.3K in stock awards.
Rankings
In 2023, Oren Gilad's compensation ranked 1,356th out of 3,006 executives tracked by ExecPay. In other words, Gilad earned more than 54.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,356 out of 3,006 | 55th |
Division Manufacturing | 813 out of 1,650 | 51st |
Major group Chemicals And Allied Products | 537 out of 918 | 42nd |
Industry group Drugs | 524 out of 881 | 41st |
Industry Pharmaceutical Preparations | 364 out of 637 | 43rd |
Source: SEC filing on April 25, 2024.
Gilad's colleagues
We found two more compensation records of executives who worked with Oren Gilad at Aprea Therapeutics in 2023.